Search Results
Found 2 results
510(k) Data Aggregation
K Number
DEN210056Device Name
Procise IFX
Manufacturer
Date Cleared
2023-09-29
(660 days)
Product Code
Regulation Number
862.3115Why did this record match?
Applicant Name (Manufacturer) :
ProciseDx Inc.
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Procise IFX assay is a time-resolved fluorescence energy transfer immunoassay for the quantitative determination of infliximab levels in venous serum in patients undergoing infliximab therapy, using the ProciseDx Analyzer.
Measurements obtained by this assay can be used to detect infliximab as an aid in the management of patients with inflammatory bowel diseases (IBD): Crohn's disease and ulcerative colitis being treated with infliximab. The test is intended for use in a clinical laboratory.
Device Description
Each Procise IFX assay kit includes Procise IFX reagent cartridges, buffer bulbs, and Procise IFX low and high assay controls as follows:
- Twenty pouched Procise IFX cartridges each containing a lyophilized test-specific reagent bead contains a dry reagent bead located in the cartridge cap comprised of < 50 ug of test-specific conjugates (monoclonal Fab anti-IFX/TNFa complex labeled with acceptor fluorophore and TNFa labeled with donor fluorophore)
- Twenty 1.5mL buffer bulbs .
- Two pouched assay IFX Low controls
- Two pouched assay IFX High controls .
- Product Insert
- Quick Reference Guide .
The Procise IFX assay requires the ProciseDx Analyzer. The ProciseDx Analyzer is designed to detect time-resolved fluorescent signal from both the donor and FRET acceptor emission within the Procise IFX assay.
Ask a Question
Ask a specific question about this device
K Number
DEN220023Device Name
Procise ADL
Manufacturer
Date Cleared
2023-09-29
(543 days)
Product Code
Regulation Number
862.3115Why did this record match?
Applicant Name (Manufacturer) :
ProciseDx Inc.
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Procise ADL assay is a time-resolved fluorescence energy transfer immunoassay for the quantitative determination of adalimumab (ADL) levels in venous serum in patients undergoing adalimumab therapy, using the ProciseDx Analyzer.
Measurements obtained by this assay can be used to detect adalimumab as an aid in the management of patients with inflammatory bowel diseases (IBD): Crohn's disease and ulcerative colitis being treated with adalimumab. The test is intended for use in a clinical laboratory.
Device Description
Each Procise ADL assay kit includes Procise ADL reagent cartridges, buffer bulbs, and Procise ADL low and high assay controls as follows:
- . Twenty pouched Procise ADL cartridges each containing a lyophilized test-specific reagent bead located in the cartridge cap comprised of test-specific conjugates (monoclonal Fab anti-ADL/TNFa complex labeled with acceptor fluorophore and TNFa protein labeled with donor fluorophore)
- Twenty 1.5 mL buffer bulbs .
- . Two pouched assay ADL Low controls
- . Two pouched assay ADL High controls
- Product Insert .
- . Quick Reference Guide
The Procise ADL assay requires the ProciseDx Analyzer. The ProciseDx Analyzer is designed to detect time-resolved fluorescent signal from both the donor and FRET acceptor emission within the Procise ADL assay.
Ask a Question
Ask a specific question about this device
Page 1 of 1